The Diagnostic Journey: Testing and Imaging for EKC

Diagnosing Erythrokeratodermia-cardiomyopathy (EKC) syndrome is a multi-step process because the condition affects different systems at different times. Because the heart involvement can be “silent”—meaning you feel perfectly fine while the heart muscle is changing—doctors rely on a specific set of high-tech tests to confirm the diagnosis and monitor for risks ^[1][2].

The Genetic Blueprint: DSP Testing

The most definitive way to confirm EKC is through genetic testing. This is typically done using a multigene panel that looks at dozens of genes related to the heart and skin, specifically focusing on the DSP gene ^[3][4].

A complete genetic evaluation should include:

• Full Sequencing: Reading the entire code of the DSP gene to find small “misspellings” (missense variants) ^[1].
• Deletion/Duplication Analysis: Checking for larger missing or extra chunks of the gene (also called copy-number analysis) ^[5].
• Parental Testing: Checking parents to see if the mutation is “de novo” (new in the patient) or inherited. This is vital for understanding the risk to other family members ^[6][7]. A genetic test might return a variant of uncertain significance, which does not automatically establish or exclude EKC without specialist interpretation.

The Cellular Clues: Skin Biopsy

While a visual exam of the skin is the first step, a biopsy (taking a tiny sample of skin) provides the cellular evidence of EKC. Under a microscope, pathologists look for a specific breakdown of the “cellular glue” ^[1]. A skin biopsy is a supportive test and may not necessarily be required if genetic testing is clear.

• Desmosomal-type Acantholysis: This is the technical term for skin cells pulling away from each other because their “anchors” (desmosomes) are failing ^[8].
• Widened Intercellular Spaces: You might see this on a report; it means the gaps between your skin cells are larger than they should be ^[1].
• Immunostaining: Doctors may use special dyes to see if the desmoplakin protein is actually in the right place within the cells ^[1][9].

The Heart Watch: Cardiac Imaging and Monitoring

Because EKC can cause a “left-dominant” or “biventricular” cardiomyopathy (affecting one or both sides of the heart), an echocardiogram remains a core first-line test to measure heart chamber size and ejection fraction, but it is often complemented by other tools ^[10][11].

Cardiac MRI (CMR)

This is a complementary imaging tool for EKC. It uses powerful magnets to see the structure of the heart and, more importantly, to find microscopic scar tissue ^[11]. Testing is individualized by age, renal function, pregnancy, and whether a young child needs sedation.

• Late Gadolinium Enhancement (LGE): Doctors inject a contrast dye (gadolinium). If the dye “sticks” to the heart muscle during the late phase of the scan, it indicates areas of fibrosis (scarring) ^[11][12]. In EKC, this scarring can occur even when the heart’s pumping strength is still normal ^[12].

Rhythm Monitoring (Holter)

A Holter monitor is a wearable device that records every single heartbeat for 24 hours or more. In patients with DSP mutations, doctors look for specific thresholds:

• PVCs > 500: While finding more than 500 Premature Ventricular Contractions (extra heartbeats) in a 24-hour period can be considered a risk marker by some specialists, PVCs alone do not diagnose DSP cardiomyopathy. Their meaning depends on age, symptoms, and ventricular function ^[11].
• NSVT (Nonsustained Ventricular Tachycardia): This refers to short bursts of a rapid, dangerous heart rhythm. This is a significant predictor of future heart risks ^[11][13].

Understanding Your Reports: A Glossary

• Acantholysis: The loss of connection between skin cells ^[1].
• Ejection Fraction (EF): A percentage that measures how much blood the heart pumps out with each beat. “Reduced LVEF” means the left side of the heart is weakening ^[11].
• Fibrosis: Medical shorthand for scarring in the heart muscle ^[12].
• LGE (Late Gadolinium Enhancement): A sign of scarring or inflammation found on a cardiac MRI ^[11].
• NSVT: Short, “nonsustained” runs of a fast heart rhythm that starts in the lower chambers ^[13].
• PVC (Premature Ventricular Contraction): An extra heartbeat that starts in the heart’s lower pumping chambers ^[11].
• T-wave Inversion: A specific pattern on an ECG (electrocardiogram) that can be a warning sign of heart muscle disease ^[14]. These findings are nonspecific and can be age-dependent, especially in children.

Tests That May Be Considered

Ensure your care team has considered the following:

Cardiac Evaluation

• [ ] Cardiac MRI with Late Gadolinium Enhancement (LGE)
• [ ] 24-Hour Holter Monitor (specifically checking for PVC burden and NSVT)
• [ ] 12-Lead ECG (checking for T-wave inversions or low-voltage QRS)
• [ ] Echocardiogram to measure Ejection Fraction (EF)

Genetic & Pathological Evaluation

• [ ] Multigene Panel including full DSP sequencing
• [ ] Deletion/Duplication Analysis (Copy-number variants)
• [ ] Skin Biopsy with pathology review for acantholysis
• [ ] Cascade Screening plan for at-risk family members ^[7]